Brookstone Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Brookstone Capital Management's ABMD Position: Q4 2022 in Review
Brookstone Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,547 shares — an estimated $376K sold.
Brookstone Capital Management first reported a position in ABMD in Q1 2018 and held it in 19 quarters. The position peaked at $4.58M in Q3 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Brookstone Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Brookstone Capital Management sold 1,547 Abiomed Inc shares in Q4 2022, an estimated $376K.
- Brookstone Capital Management first reported a position in Abiomed Inc in Q1 2018 and held it in 19 quarters.
- Brookstone Capital Management's Abiomed Inc position peaked at $4.58M in Q3 2020.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Brookstone Capital Management's 13F filing for Q4 2022, filed 9 Jan 2023.